Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2013 / Cilt: 22 - Sayı: 2

Akut böbrek hasarı ve prostat kanserli olguda Anti-dsDNA pozitifliği: olgu sunumu

Anti-dsDNA positivity in a patient with prostate cancer and acute kidney ınjury: a case report

Pages
221–223
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The subject was positive for Anti-dsDNA ab with a value of 96 IU/ml (normal,

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Patients with malignancies may develop autoimmune and rheumatic manifestations as a result of generation of autoantibodies, paraneoplastic syndromes, direct invasion of joints and muscles by the tumour cells, or combination chemotherapy.
📊
Key Findings & Data:CASE PRESENTATION: The 78-year-old male patient applied to our center with the complaint of generalized bone pain since approximately two months, and rapid onset of weakness, oliguria and dysuria for three days.
💡
Conclusion & Impact:The subject was positive for Anti-dsDNA ab with a value of 96 IU/ml (normal,
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Patients with malignancies may develop autoimmune and rheumatic manifestations as a result of generation of autoantibodies, paraneoplastic syndromes, direct invasion of joints and muscles by the tumour cells, or combination chemotherapy. We present a case with prostate cancer and acute kidney injury (AKI) mimicking rapidly progressive glomerulonephritis with a positive test result for anti-double-stranded deoxyribonucleic acid antibodies (Anti-dsDNA ab). CASE PRESENTATION: The 78-year-old male patient applied to our center with the complaint of generalized bone pain since approximately two months, and rapid onset of weakness, oliguria and dysuria for three days. He had been diagnosed metastatic prostate cancer (PC) for two years and at the time of application had received high dose of naproxen sodium because of severe bone pain for 5 days. Serum creatinine level was elevated on admission (2.4 mg/dl). Urinalysis revealed microscopic hematuria, granular casts and proteinuria of 1.2 gr/day. Immunologic tests including Anti-dsDNA antibody were done regarding acute nephritic syndrome. The subject was positive for Anti-dsDNA ab with a value of 96 IU/ml (normal,

Özet

AMAÇ: Maligniteye sahip hastalarda otoimmün ve romatolojik olaylar meydana gelebilmektedir. Bu özellikler; kombinasyon kemoterapilerinin kullanımından, tümor hücrelerinin eklem ve kasları direk tolarak invaze etmesinden, paraneoplastik sendromlardan, otoantikorlardan kaynaklanır. Bu vakada biz hızlı ilerleyen glomerülonefriti taklit eden akut böbrek yetmezlikli, prostat kanserli bir olguda görülen Anti-double-stranded deoxyribonucleic acid antibodies (Anti-dsDNA ab) pozitifliğini sunmayı amaçladık. OLGU SUNUMU: 78 yaşında erkek hasta, 2 aydır yaygın kemik ağrısı, ani başlangıçlı zayıflama, 3 gündür ortaya çıkan dizüri, oligüri şikayetleri nedeniyle hastaneye yatırıldı. 2 yıldır metastatik prostat kanser tanısı mevcuttu. 5 gündür yaygın kemik ağrısından dolayı naproksen sodyum kullanmaktaydı. Serum kreatinin düzeyi hastaneye yatışında yüksek tespit edildi (2,4 mg/dl). Tam idrar tetkikinde; mikroskopik hematüri, 1,2 gr/gün proteinürisi mevcuttu. Anti-dsDNA pozitif idi (96 IU/ml [normal,

🔖

Cite This Article

TURGUTALP, K., KIYKIM, A., GÖK, E. O., AKÇA, M. (2022). Akut böbrek hasarı ve prostat kanserli olguda Anti-dsDNA pozitifliği: olgu sunumu. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 22 - Sayı: 2, 221–223. https://ajindex.com/articles/655007

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Abu-Shakra M, Buskila D, Ehrenfeld M, Conrad K, Shoenfeld Y: Cancer and autoimmunity: Autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 2001; 60: 433-441 2. Faria TV, Baptista MA, Burdmann EA, Cury PM: Renal glomerular alterations in patients with cancer: A clinical and immunohistochemical autopsy study. Ren Fail 2010; 32(8): 918-922 3. Kavanaugh, AF, Solomon DH; American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines: Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti- DNA antibody tests. Arthritis Rheum 2002; 47: 546 4. Ioannou Y, Isenberg DA: Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 2000; 43: 1431-1432 5. Attar SM, FRCPC, FACP, Emad A: Koshak Medical conditions associated with a positive anti-doublestranded deoxyribonucleic acid. Saudi Med J 2010; 31(7): 781-787 6. Greenlee JE, Clawson SA, Hill KE, Dechet CB, Carlson NG: Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate. J Neurol Sci 2010; 291(1-2): 74-78 7. Fukushima S, Egawa K, Nishi H, Wakasugi S, Ishii N, Hashimoto T, Yancey KB, Ihn H: Two cases of anti-epiligrin cicatricial pemphigoid with and without associated malignancy. Acta Derm Venereol 2008; 88(5): 484-487 8. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S: Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004; 62(7): 1177-1182 9. Schiavo N, Lottermann AL, Costa FP, Staub HL: Antiphospholipid antibodies, thrombosis, and adenocarcinoma. Clinics (Sao Paulo) 2005; 60(3): 257-258